Systemic treatment of adrenocortical carcinoma in children: Data from the German GPOH-MET 97 trial

Klinische Padiatrie

Volumn 224, Issue 6, 2012, Pages 366-371

  Redlich, A ^a   Boxberger, N ^a   Strugala, D ^a   Fruhwald M C ^b   Leuschner, I ^c   Kropf, S ^a   Bucsky, P ^d   Vorwerk, P ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c UNIVERSITY OF KIEL   (Germany)

^d UNIVERSITY OF LÜBECK   (Germany)

Author keywords

GPOH MET 97 Protokoll; Kinderonkologie; Mitotane; Nebennierenrindenkarzinom; neoadjuvante Chemotherapie

Indexed keywords

CARBOPLATIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; MITOTANE; VINCRISTINE;

ADOLESCENT; ADRENAL CORTEX CARCINOMA; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHILD; DISEASE ASSOCIATION; DISEASE COURSE; DRUG BLOOD LEVEL; FEMALE; HUMAN; INFANT; INOPERABLE CANCER; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; PRESCHOOL CHILD; SALVAGE THERAPY; SCHOOL CHILD; SEX DIFFERENCE; SINGLE DRUG DOSE; SYSTEMIC THERAPY; TREATMENT DURATION; TUMOR VOLUME;

ADRENAL CORTEX NEOPLASMS; ADRENALECTOMY; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MITOTANE; NEOADJUVANT THERAPY; NEOPLASM STAGING; SALVAGE THERAPY;

EID: 84868495925     PISSN: 03008630     EISSN: 14393824     Source Type: Journal    
DOI: 10.1055/s-0032-1327579     Document Type: Article

References (30)

1. Allolio B., Hahner S., Weismann D. et al. Management of adrenocortical carcinoma. Clin Endocrinol (Oxf): 2004; 60 273 287 (Pubitemid 38297116)
2. Berruti A., Ferrero A., Sperone P. et al. Emerging drugs for adrenocortical carcinoma. Expert Opin Emerg Drugs: 2008; 13 497 509
3. Berruti A., Terzolo M., Pia A. et al. Mitotane associated with etoposide, doxorubicin, and cisplatin in the treatment of advanced adrenocortical carcinoma. Italian Group for the Study of Adrenal Cancer. Cancer: 1998; 83 2194 2200 (Pubitemid 28525402)
4. Berruti A., Terzolo M., Sperone P. et al. Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial. Endocr Relat Cancer: 2005; 12 657 666 (Pubitemid 41482999)
5. Bucsky P. Interdisziplinäre multizentrische Therapieoptimierungsstudie: Maligne endokrine Tumoren im Kindes- und Jugendalter GPOH-MET 97. Gesellschaft für Pädiatrische Onkologie und Hämatologie (GPOH): 1997
6. Ciftci A. O., Senocak M. E., Tanyel F. C. et al. Adrenocortical tumors in children. J Pediatr Surg: 2001; 36 549 554 (Pubitemid 32268337)
7. Daffara F., De F. S., Reimondo G. et al. Prospective evaluation of mitotane toxicity in adrenocortical cancer patients treated adjuvantly. Endocr Relat Cancer: 2008; 15 1043 1053
8. Dehner L. P., Hill D. A. Adrenal cortical neoplasms in children. Why so many carcinomas and yet so many survivors? Pediatr Dev Pathol: 2009; 12 284 291
9. Fassnacht M., Allolio B. Clinical management of adrenocortical carcinoma. Best Pract Res Clin Endocrinol Metab: 2009; 23 273 289
10. Fassnacht M., Johanssen S., Fenske W. et al. Improved survival in patients with stage II adrenocortical carcinoma followed up prospectively by specialized centers. J Clin Endocrinol Metab: 2010; 95 4925 4932
11. Fassnacht M., Terzolo M., Allolio B. et al. Combination chemotherapy in advanced adrenocortical carcinoma. N Engl J Med: 2012; 366 2189 2197
12. Göbel U., Gortner L. Disease management programs for adults with often diseases and competence networks for children and adolescents with rare diseases. Klin Padiatr: 2011; 223 1 3
13. Golden S. H., Robinson K. A., Saldanha I. et al. Clinical review: prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review. J Clin Endocrinol Metab: 2009; 94 1853 1878
14. Grubbs E. G., Callender G. G., Xing Y. et al. Recurrence of adrenal cortical carcinoma following resection: surgery alone can achieve results equal to surgery plus mitotane. Ann Surg Oncol: 2010; 17 263 270
15. Hanna A. M., Pham T. H., Skegard-Giesmann J. R. et al. Outcome of adrenocortical tumors in children. J Pediatr Surg: 2008; 43 843 849 (Pubitemid 351657538)
16. Huang H., Fojo T. Adjuvant mitotane for adrenocortical cancer - a recurring controversy. J Clin Endocrinol Metab: 2008; 93 3730 3732
17. Hubertus J., Boxberger N., Redlich A. et al. Surgical aspects in the treatment of adrenocortical carcinomas in children: data from the GPOH-MET 97 Trial. Klin Padiatr: 2012; 224 143 147
18. Johanssen S., Hahner S., Saeger W. et al. Deficits in the management of patients with adrenocortical carcinoma in Germany. Dtsch Arztebl Int: 2010; 107 885 891
19. Lacroix A. Approach to the patient with adrenocortical carcinoma. J Clin Endocrinol Metab: 2010; 95 4812 4822
20. Loncarevic I. F., Hering A., Posorski N. et al. Number of imbalances correlates with the overall survival for adrenocortical cancer in childhood. Pediatr Blood Cancer: 2008; 51 356 362
21. Michalkiewicz E., Sandrini R., Figueiredo B. et al. Clinical and outcome characteristics of children with adrenocortical tumors: a report from the International Pediatric Adrenocortical Tumor Registry. J Clin Oncol: 2004; 22 838 845 (Pubitemid 41103595)
22. Parlowsky T., Bucsky P., Hof M. et al. Malignant endocrine tumours in childhood and adolescence - results of a retrospective analysis. Klin Padiatr: 1996; 208 205 209 (Pubitemid 26246752)
23. Parlowsky T., Dralle H., Farahati J. et al. Maligne endokrine Tumoren im Kindesalter. Eine interdisziplinäre multizentrische Therapieoptimierungsstudie. Deutsches Ärzteblatt: 2001; 98 A764 A767
24. Polat B., Fassnacht M., Pfreundner L. et al. Radiotherapy in adrenocortical carcinoma. Cancer: 2009; 115 2816 2823
25. Ribeiro R. C., Figueiredo B. Childhood adrenocortical tumours. Eur J Cancer: 2004; 40 1117 1126 (Pubitemid 38526330)
26. Rodriguez-Galindo C., Figueiredo B. C., Zambetti G. P. et al. Biology, clinical characteristics, and management of adrenocortical tumors in children. Pediatr Blood Cancer: 2005; 45 265 273 (Pubitemid 41077159)
27. Sandrini R., Ribeiro R. C., DeLacerda L. Childhood adrenocortical tumors. J Clin Endocrinol Metab: 1997; 82 2027 2031
28. Schneider D. T., Brecht I. B. Care for rare cancers: improved care requires improved communication. Klin Padiatr: 2010; 222 124 126
29. Terzolo M., Fassnacht M., Ciccone G. et al. Adjuvant mitotane for adrenocortical cancer-working through uncertainty. J Clin Endocrinol Metab: 2009; 94 1879 1880
30. Wieneke J. A., Thompson L. D., Heffess C. S. Adrenal cortical neoplasms in the pediatric population: a clinicopathologic and immunophenotypic analysis of 83 patients. Am J Surg Pathol: 2003; 27 867 881 (Pubitemid 36758889)